149 results
Page 4 of 8
6-K
EX-99.1
paiis flmrwgpseg
16 Mar 22
2021 Annual Report A nn ua l R ep or t 20 21
4:55pm
6-K
EX-99.1
pff4rc9i9
13 Dec 21
MorphoSys presents latest data from the Phase 2 MANIFEST Study evaluating the potential of pelabresib in the treatment of myelofibrosis
10:14am
6-K
EX-99.1
ajsc65u04gc8
13 Dec 21
Current report (foreign)
9:56am
6-K
EX-99.1
4otecb7sl2sht7odl2py
12 Nov 21
MorphoSys AG Reports First Nine Months and Third Quarter
8:30am
6-K
EX-99.2
t93rigz
12 Nov 21
MorphoSys AG Reports First Nine Months and Third Quarter
8:30am
6-K
EX-99.1
w8ud61h
10 Nov 21
Third Quarter Interim Statement JANUARY – SEPTEMBER
4:05pm
6-K
EX-99.1
vwkwf0a qvade
5 Nov 21
MorphoSys presents interim results from M-PLACE study with felzartamab during American Society of Nephrology Annual Meeting
7:13am
6-K
EX-99.1
i55xmwk0y ch5rz5ef
4 Nov 21
Current report (foreign)
9:50am
6-K
EX-99.1
wdk9m3w32wnn1rnwc
27 Aug 21
MorphoSys and Incyte Announce the European Commission
6:15am
6-K
EX-99.1
060unxhg
25 Aug 21
Current report (foreign)
6:39am
6-K
EX-99.1
vombk
29 Jul 21
MorphoSys AG Reports Second Quarter and First Half
12:33pm
6-K
EX-99.1
4m8c3ipvem64m
28 Jul 21
Half-Year Report January – June 2021
5:10pm
6-K
EX-99.1
t2usltm kuplxaez
25 Jun 21
Current report (foreign)
10:47am
SC TO-T
EX-99
z5zzcho9x
16 Jun 21
Third party tender offer statement
4:52pm
SC TO-T
EX-99
abn4t8jadpppp4ea
16 Jun 21
Third party tender offer statement
4:52pm
6-K
EX-99.1
yzatbs9z2n5aor4n9
4 Jun 21
Presentation will be available on demand as part of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
3:04pm
SC TO-C
EX-99.1
bxmxlaxu
2 Jun 21
Information about tender offer
5:20pm
SC TO-C
EX-99.2
iluh9i3j9ystf1u3gs
2 Jun 21
Information about tender offer
5:20pm
SC TO-C
EX-99.3
7c7pk4j inhbh
2 Jun 21
Information about tender offer
5:20pm